| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communications |






From the Departments of Pathology,*
Oncology,
Surgery,
and Medicine,
The Johns Hopkins Medical
Institutions, Baltimore, Maryland
Using the National Center for Biotechnology Information Serial
Analysis of Gene Expression database, we found that
S100A4, a calcium-binding protein previously implicated in
metastasis, was expressed in five of seven pancreatic carcinoma
libraries but not in the two normal pancreatic duct libraries. We
confirmed the overexpression of S100A4 using reverse
transcriptase-polymerase chain reaction, which demonstrated
that 18 of 19 (95%) pancreatic carcinoma cell lines expressed
S100A4. Using immunohistochemistry, we found
that 57 of 61 invasive pancreatic carcinomas (93%), 3 of 18
high-grade pancreatic intraepithelial neoplasia lesions (17%),
and 0 of the 69 low-grade pancreatic intraepithelial neoplasia lesions
expressed S100A4 protein, whereas normal pancreatic tissue and
tissue affected by chronic pancreatitis did not label. Expression of
S100A4 was associated with poor differentiation of the pancreatic
adenocarcinomas (P = 0.001). We found that three
CpG sites in the first intron of the S100A4 gene
were
90% methylated in microdissected normal pancreatic
duct cells using bisulfite-modified sequencing and in two cell lines
and three primary pancreatic carcinomas with a reduced or absent
expression of S100A4. In contrast, these CpGs were 100%
hypomethylated in 11 of 12 pancreatic cancer cell lines by
methylation-specific polymerase chain reaction. The association between
the expression of S100A4 and hypomethylation of the first intron of
S100A4 was statistically significant
(P = 0.002). These data suggest that the majority
of pancreatic carcinomas undergo selection for hypomethylation and
overexpression of S100A4. Because most pancreatic carcinomas express
S100A4, it may be a useful target for early detection
strategies.
Related articles in Am J Pathol:
This article has been cited by other articles:
![]() |
P. C. Mahon, P. Baril, V. Bhakta, C. Chelala, K. Caulee, T. Harada, and N. R. Lemoine S100A4 Contributes to the Suppression of BNIP3 Expression, Chemoresistance, and Inhibition of Apoptosis in Pancreatic Cancer Cancer Res., July 15, 2007; 67(14): 6786 - 6795. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. LEE, J. W. KIM, G. H. KANG, N. H. PARK, Y. S. SONG, S. B. KANG, and H. P. LEE DNA Hypomethylation of CAGE Promotors in Squamous Cell Carcinoma of Uterine Cervix Ann. N.Y. Acad. Sci., December 1, 2006; 1091(1): 218 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bardeesy, K.-h. Cheng, J. H. Berger, G. C. Chu, J. Pahler, P. Olson, A. F. Hezel, J. Horner, G. Y. Lauwers, D. Hanahan, et al. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes & Dev., November 15, 2006; 20(22): 3130 - 3146. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Petersen, M. de Andrade, M. Goggins, R. H. Hruban, M. Bondy, J. F. Korczak, S. Gallinger, H. T. Lynch, S. Syngal, K. G. Rabe, et al. Pancreatic cancer genetic epidemiology consortium. Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 704 - 710. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Garrett, K. M. Varney, D. J. Weber, and A. R. Bresnick S100A4, a Mediator of Metastasis J. Biol. Chem., January 13, 2006; 281(2): 677 - 680. [Full Text] [PDF] |
||||
![]() |
A. Semov, M. J. Moreno, A. Onichtchenko, A. Abulrob, M. Ball, I. Ekiel, G. Pietrzynski, D. Stanimirovic, and V. Alakhov Metastasis-associated Protein S100A4 Induces Angiogenesis through Interaction with Annexin II and Accelerated Plasmin Formation J. Biol. Chem., May 27, 2005; 280(21): 20833 - 20841. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Chen, S. Pan, T. A. Brentnall, and R. Aebersold Proteomic Profiling of Pancreatic Cancer for Biomarker Discovery Mol. Cell. Proteomics, April 1, 2005; 4(4): 523 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. B. Prasad, A. V. Biankin, N. Fukushima, A. Maitra, S. Dhara, A. G. Elkahloun, R. H. Hruban, M. Goggins, and S. D. Leach Gene Expression Profiles in Pancreatic Intraepithelial Neoplasia Reflect the Effects of Hedgehog Signaling on Pancreatic Ductal Epithelial Cells Cancer Res., March 1, 2005; 65(5): 1619 - 1626. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ogishima, H. Shiina, J. E. Breault, L. Tabatabai, W. W. Bassett, H. Enokida, L.-C. Li, T. Kawakami, S. Urakami, L. A. Ribeiro-Filho, et al. Increased Heparanase Expression Is Caused by Promoter Hypomethylation and Up-Regulation of Transcriptional Factor Early Growth Response-1 in Human Prostate Cancer Clin. Cancer Res., February 1, 2005; 11(3): 1028 - 1036. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zou, K. S. Famulski, R. S. Parhar, E. Baitei, F. A. Al-Mohanna, N. R. Farid, and Y. Shi Microarray Analysis of Metastasis-Associated Gene Expression Profiling in a Murine Model of Thyroid Carcinoma Pulmonary Metastasis: Identification of S100A4 (Mts1) Gene Overexpression as a Poor Prognostic Marker for Thyroid Carcinoma J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6146 - 6154. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hibbs, K. M. Skubitz, S. E. Pambuccian, R. C. Casey, K. M. Burleson, T. R. Oegema Jr, J. J. Thiele, S. M. Grindle, R. L. Bliss, and A. P.N. Skubitz Differential Gene Expression in Ovarian Carcinoma: Identification of Potential Biomarkers Am. J. Pathol., August 1, 2004; 165(2): 397 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pakneshan, M. Szyf, R. Farias-Eisner, and S. A. Rabbani Reversal of the Hypomethylation Status of Urokinase (uPA) Promoter Blocks Breast Cancer Growth and Metastasis J. Biol. Chem., July 23, 2004; 279(30): 31735 - 31744. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Milutinovic, S. E. Brown, Q. Zhuang, and M. Szyf DNA Methyltransferase 1 Knock Down Induces Gene Expression by a Mechanism Independent of DNA Methylation and Histone Deacetylation J. Biol. Chem., July 2, 2004; 279(27): 27915 - 27927. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Schmidt-Hansen, J. Klingelhofer, B. Grum-Schwensen, A. Christensen, S. Andresen, C. Kruse, T. Hansen, N. Ambartsumian, E. Lukanidin, and M. Grigorian Functional Significance of Metastasis-inducing S100A4(Mts1) in Tumor-Stroma Interplay J. Biol. Chem., June 4, 2004; 279(23): 24498 - 24504. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Koopmann, P. Buckhaults, D. A. Brown, M. L. Zahurak, N. Sato, N. Fukushima, L. J. Sokoll, D. W. Chan, C. J. Yeo, R. H. Hruban, et al. Serum Macrophage Inhibitory Cytokine 1 as a Marker of Pancreatic and Other Periampullary Cancers Clin. Cancer Res., April 1, 2004; 10(7): 2386 - 2392. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sato, N. Fukushima, A. Maitra, C. A. Iacobuzio-Donahue, N. T. van Heek, J. L. Cameron, C. J. Yeo, R. H. Hruban, and M. Goggins Gene Expression Profiling Identifies Genes Associated with Invasive Intraductal Papillary Mucinous Neoplasms of the Pancreas Am. J. Pathol., March 1, 2004; 164(3): 903 - 914. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Iacobuzio-Donahue, R. Ashfaq, A. Maitra, N. V. Adsay, G. L. Shen-Ong, K. Berg, M. A. Hollingsworth, J. L. Cameron, C. J. Yeo, S. E. Kern, et al. Highly Expressed Genes in Pancreatic Ductal Adenocarcinomas: A Comprehensive Characterization and Comparison of the Transcription Profiles Obtained from Three Major Technologies Cancer Res., December 15, 2003; 63(24): 8614 - 8622. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Akiyama, C. Maesawa, S. Ogasawara, M. Terashima, and T. Masuda Cell-Type-Specific Repression of the Maspin Gene Is Disrupted Frequently by Demethylation at the Promoter Region in Gastric Intestinal Metaplasia and Cancer Cells Am. J. Pathol., November 1, 2003; 163(5): 1911 - 1919. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sato, A. Maitra, N. Fukushima, N. T. van Heek, H. Matsubayashi, C. A. Iacobuzio-Donahue, C. Rosty, and M. Goggins Frequent Hypomethylation of Multiple Genes Overexpressed in Pancreatic Ductal Adenocarcinoma Cancer Res., July 15, 2003; 63(14): 4158 - 4166. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Logsdon, D. M. Simeone, C. Binkley, T. Arumugam, J. K. Greenson, T. J. Giordano, D. E. Misek, and S. Hanash Molecular Profiling of Pancreatic Adenocarcinoma and Chronic Pancreatitis Identifies Multiple Genes Differentially Regulated in Pancreatic Cancer Cancer Res., May 15, 2003; 63(10): 2649 - 2657. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Iacobuzio-Donahue, A. Maitra, M. Olsen, A. W. Lowe, N. T. Van Heek, C. Rosty, K. Walter, N. Sato, A. Parker, R. Ashfaq, et al. Exploration of Global Gene Expression Patterns in Pancreatic Adenocarcinoma Using cDNA Microarrays Am. J. Pathol., April 1, 2003; 162(4): 1151 - 1162. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sato, N. Maehara, G. H. Su, and M. Goggins Effects of 5-Aza-2'-deoxycytidine on Matrix Metalloproteinase Expression and Pancreatic Cancer Cell Invasiveness J Natl Cancer Inst, February 19, 2003; 95(4): 327 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mazzucchelli Protein S100A4: Too Long Overlooked by Pathologists? Am. J. Pathol., January 1, 2002; 160(1): 7 - 13. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |